RecruitingPhase 1NCT06828393

A Phase 1 Study of S-1117

A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Trial of S-1117 in Healthy Volunteers

Sponsor

Seismic Therapeutic AU Pty Ltd

Enrollment

96 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Healthy Volunteer

Summary

This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called S-1117 for people with healthy volunteer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.